Newmont vs AbbVie

Side-by-side comparison of AI visibility scores, market position, and capabilities

AbbVie leads in AI visibility (90 vs 75)

Newmont

LeaderManufacturing

Enterprise

Denver world's largest gold miner (NYSE: NEM) at $18.68B 2024 revenue, 6.8M oz gold; Newcrest $19B acquisition 2023, first female CEO Natascha Viljoen Jan 2026, gold $3,000+/oz competing with Barrick for institutional mining capital.

AI VisibilityBeta
Overall Score
B75
Category Rank
#252 of 290
AI Consensus
83%
Trend
stable
Per Platform
ChatGPT
79
Perplexity
85
Gemini
85

About

Newmont Corporation is a Denver, Colorado-based gold and copper mining company — publicly traded on the New York Stock Exchange (NYSE: NEM) as an S&P 500 Materials component — operating as the world's largest gold mining company with approximately 23% of global gold production, reporting $18.68 billion in revenue in 2024 (the second-best year in company history) and producing 6.8 million attributable ounces of gold with mineral reserves of 134.1 million attributable gold ounces and 13.5 million tonnes of copper across operations in North America, South America, Australia, Africa, and Papua New Guinea. Newmont maintained $3.6 billion in cash and $7.7 billion in total liquidity as of late 2024, contributing $16 billion in total economic value in 2024 including $1.9 billion in taxes and royalties to host governments. The company's $19 billion acquisition of Newcrest Mining in 2023 — the largest gold merger in history — added tier-1 operations in Australia and Papua New Guinea, significantly expanding Newmont's copper exposure alongside gold. In a historic leadership transition, Natascha Viljoen (currently President and Chief Operating Officer) will succeed Tom Palmer as President and CEO effective January 1, 2026, becoming the first woman to lead Newmont in its 100+ year history. Newmont has been named the mining sector leader on the Dow Jones Sustainability Index for nine consecutive years.

Full profile

AbbVie

LeaderHealthcare

General

Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.

AI VisibilityBeta
Overall Score
A90
Category Rank
#9 of 1167
AI Consensus
60%
Trend
stable
Per Platform
ChatGPT
99
Perplexity
99
Gemini
83

About

AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.

Full profile

AI Visibility Head-to-Head

75
Overall Score
90
#252
Category Rank
#9
83
AI Consensus
60
stable
Trend
stable
79
ChatGPT
99
85
Perplexity
99
85
Gemini
83
83
Claude
96
80
Grok
95

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.